ALYREF and posterior cortical atrophy: Ultimately, six CARMRs (ALYREF, DNMT1, DNMT3B, EXO1, HNRNPA2B1, TRDMT1) were included in our analysis to establish a prognostic model for estimating the risk of PCa recurrence.